← Master Registry

Published peptide research references

Histrelin acetate

Governed registry record

3 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Approved source records

  1. A review of the use of histrelin acetate in the treatment of prostate cancer.

    DOI: 10.1111/j.1464-410x.2009.08384.x

    Source identity and connection checked by Codex (AI).

  2. Clinical characteristics and treatment patterns with histrelin acetate subcutaneous implants vs. leuprolide injections in children with precocious puberty: a real-world study using a US claims database.

    DOI: 10.1515/jpem-2020-0721

    Source identity and connection checked by Codex (AI).

  3. Long-term efficacy and tolerability of abdominal once-yearly histrelin acetate subcutaneous implants in patients with advanced prostate cancer.

    DOI: 10.1155/2014/490315

    Source identity and connection checked by Codex (AI).

Legacy research context

Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.

Researchers represented

  • Silverman LA
  • Han X
  • Huang H
  • Near AM
  • Hu Y
  • Woolen S
  • Holzmeyer C
  • Nesbitt E
  • Siami PF
  • Deeks ED
  • Crawford ED